Related Experiment Video
Updated: Jul 9, 2026
12:55
Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
Published on: February 16, 2015
[Adoptive immunotherapy of malignancies]
Vestnik Rossiiskoi Akademii Meditsinskikh Nauk
|December 18, 2007
Summary
Human leukocytes can be developed into lymphokine-activated killers (LAKs) with potent anti-tumor effects. These LAKs show promise for adoptive immunotherapy and preventing cancer recurrence after surgery.
Area of Science:
- Immunology
- Cellular Biology
- Oncology
Context:
- Mononuclear leukocytes are key immune cells found in peripheral blood, malignant effusions, and spleen.
- Lymphokine-activated killer (LAK) cells represent a subset of immune cells with cytotoxic capabilities.
- Adoptive immunotherapy is an emerging strategy for cancer treatment.
Purpose:
- To investigate the generation of lymphokine-activated killer (LAK) cells from human mononuclear leukocytes.
- To characterize the anti-tumor activity of generated LAK cells.
- To evaluate the potential therapeutic applications of LAK cells in oncology.
Summary:
- Mononuclear leukocytes from human peripheral blood, malignant effusions, and spleen were successfully differentiated into LAK cells.
- These LAK cells exhibited significant anti-tumor activity in vitro.
- The study demonstrates the feasibility of generating cytotoxic LAK cells from readily accessible primary human tissues.
Impact:
- LAK cell therapy holds potential for treating malignant effusions.
- This approach may aid in preventing tumor recurrence in cancer patients post-surgery.
- The findings support the development of novel adoptive immunotherapy strategies for cancer treatment.
More Related Videos
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:40Cell-mediated Immune Responses
Overview
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...